LATEST VERIFIED AI EXECUTION
Our quantitative model captured a massive +11.41% net profit on $TIP.MI in just 121h 17m. Stop guessing, start executing.
$ONCIN.OL
Oncoinvent ASA
NORWAYLAST 10 EARNINGS GAPS (%)
QUANTITATIVE LIVE RADAR BLOTTER
Institutional execution stream for $ONCIN.OL
| Execution Date | Strategy & Setup | Direction | Execution Range | Hold Time | Exit Trigger | Net PnL |
|---|---|---|---|---|---|---|
| RADAR SCANNING: WAITING FOR NEXT CATALYST | ||||||
Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.
VOLATILITY & BIAS PROFILE
Intelligence Brief
Oncoinvent ASA operates as a clinical-phase biotechnology company, which engages in the development of radiopharmaceutical treatment products for cancer therapy. Its focus product is Radspherin, which uses the alpha-emitting radionuclide radium-224 that targets residual micrometastases after surgery in the abdominal cavity. The company was founded by Roy H. Larsen, Øyvind Bruland, Dr. Tina Bønsdorff, and Dr. Thora Jonasdottir on December… Read full dossier